Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that ...

The recall comes after the maker determined the drug may not dissolve or release its active ingredient in a way that meets ...

Your prescription may be involved. The FDA explains why suddenly stopping your medication is more harmful than taking it.

New Jersey-based Ascend Laboratories has voluntarily recalled 141,984 bottles of atorvastatin calcium, a cholesterol-lowering ...

The FDA announced a nationwide recall of over 140,000 bottles of a prescription cholesterol medication due to “failed ...

The study focuses on mycophenolate, a medication used primarily in organ transplantation and autoimmune diseases, to monitor pregnancy outcomes and potential birth defects. This is part of a Risk ...

Ascend Laboratories, LLC, a New Jersey-based pharmaceutical company, has recalled over 141,000 bottles of cholesterol medication. An advisory from the company suggests that the drugs may have failed ...

The US Food and Drug Administration has issued a recall of more than 140,000 bottles of Atorvastatin Calcium, a generic ...

The Delhi High Court has restrained Alchem International Pvt. Ltd., incorporated in the year 1982, from infringing the trademark of Alkem Laboratories Ltd., a company engaged in manufacture ...

For the latest installment in what’s become somewhat of a routine, European drug regulators are cracking down on data manipulation originating in India’s biopharma industry. This time, it’s Mumbai’s ...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when ...

Based on the one-year price targets offered by 17 analysts, the average target price for Alkem Laboratories Ltd (NSE:ALKEM) is $5726.05 with a high estimate of $7225.00 and a low estimate of $4330.00.